Early signals of motor disorders and pleiotropic effects of statins

Author:

Jimenez-Serrania Maria-Isabel

Abstract

The most spread drugs to treat dyslipidemia alone or with hypertriglyceridemia are statins. These active ingredients are considered safe and effective. But, with all drugs, there are adverse reactions related to them, in this case, muscular disorders such as myalgia and the complication of rhabdomyolysis. Furthermore, other adverse reactions are less studied but interesting to know, such as motor disorders. Pharmacovigilance tools must maintain the tracing of risks for effects that appear and search for positive signals; one of them is to analyze suspected adverse drug reactions of active ingredients reported through the international repository of the World Health Organization with an adaptation of data mining Bayesian methodology. Surprisingly, almost all positive motor signals are not stated as adverse drug reactions in technical factsheets and, at the same time, are related to some pleiotropic effects of statins. This chapter tries to summarize this evidence for specific pairs of statins and potential motor disorders for further investigation.

Publisher

IntechOpen

Reference52 articles.

1. Lippi G, Mattiuzzi C, Cervellin G. Statins popularity: A global picture. British Journal of Clinical Pharmacology. 2019;(7):1614-1615. DOI: 10.1111/bcp.13944

2. Adhyaru BB, Jacobson TA. Safety and efficacy of statin therapy. Nature Reviews. Cardiology. 2018;(12):757-769. DOI: 10.1038/s41569-018-0098-5

3. Committee for Medicinal Products for Human Use (CHMP). Lipitor. Annex III. Summary of product characteristics, labelling and package leaflet [Internet]. 2013. Available from: . [Accessed: October 17, 2022)

4. Committee for Proprietary Medicinal Products. Opinion following an Article 36 referral. Cerivastatin [Internet]. 2002. Available from: . [Accessed: October 17, 2022]

5. Committee for Medicinal Products for Human Use (CHMP). Zocor. Annex III. Summary of product characteristics, labelling and package leaflet [Internet]. 2004. Available from: . [Accessed: October 12, 2022]

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3